Found 5 matching trials
A Study to Evaluate the Effects of MK-0249 and an Alzheimer's Disease Medication on Cognitive Function in Adults With Alzheimer's Disease (MK-0249-023) PHASE1 This study will evaluate acute symptomatic improvements in cognitive perfor...
Show More Location
Multiple Locations
Learn More & Join Trial
MK0249 for the Treatment of Cognitive Impairment in Patients With Schizophrenia (0249-016) PHASE2 The purpose of this study is to determine the safety and effectiveness of a...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study to Test the Safety and Efficacy of MK0249 in Patients With ADHD (0249-018)(COMPLETED) PHASE2 The purpose of this study is to investigate the safety and efficacy of an i...
Show More Location
Multiple Locations
Learn More & Join Trial
Treatment of Refractory Excessive Daytime Sleepiness in Patients With Obstructive Sleep Apnea/Hypopnea Syndrome (OSA/HS) Using Nasal Continuous Positive Airway Pressure (nCPAP) Therapy (0249-015) PHASE2 The purpose of this study is to determine the safety and efficacy of MK0249...
Show More Location
Multiple Locations
Learn More & Join Trial
MK0249 for the Symptomatic Treatment of Alzheimer's Disease (MK0249-011) PHASE2 The purpose of this study is to test the efficacy and safety of an investig...
Show More Location
Multiple Locations
Learn More & Join Trial